Target intelligence / Profile preview

Riboflavin-dependent oxidoreductase enzyme

Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Riboflavin-dependent oxidoreductase enzymes are a large family of flavoproteins that require the vitamin B₂-derived cofactors flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) for their catalytic activity. These enzymes catalyze oxidation-reduction reactions essential for energy production, cellular respiration, antioxidant defense, and the metabolism of carbohydrates, lipids, proteins, drugs, and toxins. They play critical roles at metabolic branch points such as cholesterol and vitamin D biosynthesis. Deficiencies or mutations affecting these flavoenzymes can result in metabolic disorders impacting multiple organ systems including the nervous system and skeleton. The group includes well-known members such as glutathione reductase and various cytochrome P450 reductases but does not refer to one unique protein target. The term "Riboflavin-dependent oxidoreductase enzymes" is overly broad and refers to a large family of enzymes rather than a single, specific molecular target. It encompasses many different proteins with diverse biological roles. The class includes many enzymes, each with its own set of interacting drugs; no single drug interacts broadly with all riboflavin-dependent oxidoreductases. Mechanisms of action vary by specific enzyme; generally involve electron transfer via FAD or FMN cofactors from NAD(P)H to substrates, often as part of redox cycles. Glutathione reductase activity in red blood cells is used as a biomarker for riboflavin status, but not specifically for all riboflavin-dependent oxidoreductases. No general safety concerns apply to the entire class; individual enzymes may have therapeutic challenges depending on their role.

Other names
FlavoenzymeFlavin-dependent oxidoreductaseFAD-dependent enzymeFMN-dependent enzyme
02

Biological functions

Redox (oxidation-reduction) reactions in metabolismEnergy production (electron transport chain)Antioxidant defense (e.g., glutathione reductase activity)Drug and toxin metabolism (via cytochrome P450 systems)
03

Disease associations

Cancer (some flavoenzymes involved in cancer prevention or progression)Cardiovascular disease (riboflavin deficiency linked to elevated homocysteine levels)Inborn errors of metabolism affecting flavoproteins can cause neurological and skeletal disorders

Beyond the preview

Go deeper on Riboflavin-dependent oxidoreductase enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Riboflavin-dependent oxidoreductase enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call